The Korean Journal of Internal Medicine (Sep 2024)

2024 KSoLA consensus on secondary dyslipidemia

  • Hoyoun Won,
  • Jae Hyun Bae,
  • Hyunjung Lim,
  • Minji Kang,
  • Minjoo Kim,
  • Sang-Hak Lee,

DOI
https://doi.org/10.3904/kjim.2024.156
Journal volume & issue
Vol. 39, no. 5
pp. 717 – 730

Abstract

Read online

Elevated blood cholesterol and triglyceride levels induced by secondary causes are frequently observed. The identification and appropriate handling of these causes are essential for secondary dyslipidemia treatment. Major secondary causes of hypercholesterolemia and hypertriglyceridemia include an unhealthy diet, diseases and metabolic conditions affecting lipid levels, and therapeutic side effects. It is imperative to correct secondary causes prior to initiating conventional lipid-lowering therapy. Guideline-based lipid therapy can then be administered based on the subsequent lipid levels.

Keywords